Prevention of Domain Swapping Inhibits Dimerization and Amyloid Fibril Formation of Cystatin C: USE OF ENGINEERED DISULFIDE BRIDGES, ANTIBODIES, AND CARBOXYMETHYLPAPAIN TO STABILIZE THE MONOMERIC FORM OF CYSTATIN C
Open Access
- 4 June 2004
- journal article
- Published by Elsevier
- Vol. 279 (23), 24236-24245
- https://doi.org/10.1074/jbc.m402621200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation processNature Structural & Molecular Biology, 2003
- Crystal structure of the human prion protein reveals a mechanism for oligomerization.Nature Structural & Molecular Biology, 2001
- Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping.Nature Structural & Molecular Biology, 2001
- Cystatin C-Properties and use as diagnostic markerAdvances in Clinical Chemistry, 2001
- The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluidsAmyloid, 2001
- Cerebral amyloid angiopathy: An overviewNeuropathology, 2000
- Hereditary cystatin C amyloid angiopathyAmyloid, 2000
- Folding-related Dimerization of Human Cystatin CJournal of Biological Chemistry, 1996
- Domain swapping: entangling alliances between proteins.Proceedings of the National Academy of Sciences, 1994
- Increased body temperature accelerates aggregation ofthe Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditarycystatin C amyloid angiopathy.Proceedings of the National Academy of Sciences, 1994